We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

223 hedge funds and large institutions have $1.75B invested in PDL BioPharma, Inc. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 81 increasing their positions, 78 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 78

1% more capital invested

Capital invested by funds: $1.72B → $1.75B (+$24.3M)

3% less funds holding

Funds holding: 231 → 223 (-8)

19% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 26

55% less call options, than puts

Call options by funds: $2.02M | Put options by funds: $4.49M

Holders
223
Holders Change
-8
Holders Change %
-3.46%
% of All Funds
5.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
81
Reduced
78
Closed
26
Calls
$2.02M
Puts
$4.49M
Net Calls
-$2.47M
Net Calls Change
-$496K

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$60.1M
2
LCP
Lombardia Capital Partners
California
+$10.8M
3
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$8.36M
4
Invesco
Invesco
Georgia
+$8.08M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$7.9M

Top Sellers

Rank Fund Capital Flow
1
QI
QS Investors
New York
-$17.6M
2
Renaissance Technologies
Renaissance Technologies
New York
-$15.6M
3
NI
Numeric Investors
Massachusetts
-$7.22M
4
Wells Fargo
Wells Fargo
California
-$6.59M
5
Morgan Stanley
Morgan Stanley
New York
-$6.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
101
UBS Group
Switzerland
$764K +$784K +99,118 New
CIP
102
Convergence Investment Partners
Florida
$725K -$411K -51,960 -36%
VOYA Investment Management
103
VOYA Investment Management
Georgia
$706K – – –
DP
104
Dearborn Partners
Illinois
$702K +$367K +46,322 +103%
DekaBank Deutsche Girozentrale
105
DekaBank Deutsche Girozentrale
Germany
$662K -$63.3K -8,000 -9%
PAM
106
Panagora Asset Management
Massachusetts
$639K -$1.14M -143,875 -63%
OA
107
Oak Associates
Ohio
$625K – – –
Legal & General Group
108
Legal & General Group
United Kingdom
$624K +$2.71K +342 +0.4%
Fidelity Investments
109
Fidelity Investments
Massachusetts
$594K -$103K -13,000 -14%
Tudor Investment Corp
110
Tudor Investment Corp
Connecticut
$527K -$456K -57,600 -46%
B
111
Baird
Wisconsin
$520K +$47K +5,945 +10%
LPL Financial
112
LPL Financial
California
$517K -$69.1K -8,726 -12%
Two Sigma Investments
113
Two Sigma Investments
New York
$513K -$1.3M -164,479 -71%
AA
114
ALPS Advisors
Colorado
$513K -$30K -3,796 -5%
PNC Financial Services Group
115
PNC Financial Services Group
Pennsylvania
$510K -$103K -13,064 -16%
TD Asset Management
116
TD Asset Management
Ontario, Canada
$499K +$74.6K +9,428 +17%
GIA
117
Gargoyle Investment Advisor
New Jersey
$497K – – –
VIA
118
Vident Investment Advisory
Georgia
$483K +$496K +62,692 New
QI
119
Quotient Investors
New York
$481K -$56.2K -7,100 -10%
FIM
120
Freedom Investment Management
Connecticut
$462K +$277K +35,019 +140%
LS
121
Livforsakringsbolaget Skandia
Sweden
$460K – – –
LH
122
Lebenthal Holdings
New York
$457K +$469K +59,216 New
Public Employees Retirement Association of Colorado
123
Public Employees Retirement Association of Colorado
Colorado
$439K – – –
Commonwealth Equity Services
124
Commonwealth Equity Services
Massachusetts
$414K -$25.1K -3,170 -6%
VRS
125
Virginia Retirement Systems
Virginia
$404K – – –
3 4
5
6 7

PDLI Hedge Fund Activity: Q4 2014 in Review

223 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2014, worth a combined $1.75B — up 1.4% from $1.72B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of PDLI and 21 opened new positions — a net loss of 5 holders — while 78 trimmed existing stakes and 81 added.

The largest buyer was First Trust Advisors, adding an estimated $60.1M. The largest seller was QS Investors, cutting an estimated $17.6M.

  • 223 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2014, down from 231 in Q3 2014.
  • Funds reported $1.75B of PDL BioPharma, Inc. stock for Q4 2014, up 1.4% quarter-over-quarter.
  • 21 funds opened new PDL BioPharma, Inc. positions in Q4 2014 and 26 closed out, a net change of -5 holders.
  • The largest PDL BioPharma, Inc. buyer in Q4 2014 was First Trust Advisors, an estimated $60.1M added.
  • The largest PDL BioPharma, Inc. seller in Q4 2014 was QS Investors, an estimated $17.6M sold.

Based on aggregated 13F filings for Q4 2014.